NDC 62541-406 – Pancreaze

Pancrelipase Lipase 37000 [USP'U]/1; Pancrelipase Amylase 149900 [USP'U]/1; Pancrelipase Protease 97300 [USP'U]/1 · Capsule, Delayed Release · Oral

Human Prescription Drug 1 recall

Product NDC62541-406

Product details

Brand name
Pancreaze
Generic name
PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE
Labeler
VIVUS LLC
Dosage form
Capsule, Delayed Release
Route
Oral
Marketing category
BLA · BLA022523
Marketed since
July 1, 2021
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Pancreaze →

Package NDC codes (1)

Package NDCDescriptionSince
62541-406-102 BOTTLE, GLASS in 1 CARTON (62541-406-10) / 50 CAPSULE, DELAYED RELEASE in 1 BOTTLE, GLASS (62541-406-50)Jul 1, 2021

Recalls mentioning this NDC

Other Pancreaze products